The US Blood Component Utilization Market represents the dominant national market within North America, estimated to account for 72–76% of the regional market in 2025 and projected to grow at a 3.80–4.20% CAGR through 2034. Growth is supported by the country's extensive network of academic medical centers, trauma systems, cancer centers, blood services, and specialized transfusion...